UV-light-induced conversion and aggregation of prion proteins. 2009

Lars Redecke, and Stephan Binder, and Mohammed I Y Elmallah, and Rebecca Broadbent, and Claudia Tilkorn, and Benjamin Schulz, and Patrick May, and Arne Goos, and Andreas Eich, and Michael Rübhausen, and Christian Betzel
Institute of Biochemistry and Molecular Biology, Department of Chemistry, University of Hamburg, Germany.

Increasing evidence suggests a central role for oxidative stress in the pathology of prion diseases, a group of fatal neurodegenerative disorders associated with structural conversion of the prion protein (PrP). Because UV-light-induced protein damage is mediated by direct photo-oxidation and radical reactions, we investigated the structural consequences of UVB radiation on recombinant murine and human prion proteins at pH 7.4 and pH 5.0. As revealed by circular dichroism and dynamic light scattering measurements, the observed PrP aggregation follows two independent pathways: (i) complete unfolding of the protein structure associated with rapid precipitation or (ii) specific structural conversion into distinct soluble beta-oligomers. The choice of pathway was directly attributed to the chromophoric properties of the PrP species and the susceptibility to oxidation. Regarding size, the oligomers characterized in this study share a high degree of identity with oligomeric species formed after structural destabilization induced by other triggers, which significantly strengthens the theory that partly unfolded intermediates represent initial precursor molecules directing the pathway of PrP aggregation. Moreover, we identified the first suitable photo-trigger capable of inducing refolding of PrP, which has an important biotechnological impact in terms of analyzing the conversion process on small time scales.

UI MeSH Term Description Entries
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002942 Circular Dichroism A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Circular Dichroism, Vibrational,Dichroism, Circular,Vibrational Circular Dichroism
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D014466 Ultraviolet Rays That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants. Actinic Rays,Black Light, Ultraviolet,UV Light,UV Radiation,Ultra-Violet Rays,Ultraviolet Light,Ultraviolet Radiation,Actinic Ray,Light, UV,Light, Ultraviolet,Radiation, UV,Radiation, Ultraviolet,Ray, Actinic,Ray, Ultra-Violet,Ray, Ultraviolet,Ultra Violet Rays,Ultra-Violet Ray,Ultraviolet Black Light,Ultraviolet Black Lights,Ultraviolet Radiations,Ultraviolet Ray
D017096 Prion Diseases A group of genetic, infectious, or sporadic degenerative human and animal nervous system disorders associated with abnormal PRIONS. These diseases are characterized by conversion of the normal prion protein to an abnormal configuration via a post-translational process. In humans, these conditions generally feature DEMENTIA; ATAXIA; and a fatal outcome. Pathologic features include a spongiform encephalopathy without evidence of inflammation. The older literature occasionally refers to these as unconventional SLOW VIRUS DISEASES. (From Proc Natl Acad Sci USA 1998 Nov 10;95(23):13363-83) Dementias, Transmissible,Spongiform Encephalopathies, Transmissible,Transmissible Dementias,Encephalopathies, Spongiform, Transmissible,Human Transmissible Spongiform Encephalopathies, Inherited,Inherited Human Transmissible Spongiform Encephalopathies,Prion Disease,Prion Protein Diseases,Prion-Associated Disorders,Prion-Induced Disorder,Prion-Induced Disorders,Transmissible Spongiform Encephalopathies,Dementia, Transmissible,Disorder, Prion-Induced,Disorders, Prion-Induced,Encephalopathies, Transmissible Spongiform,Encephalopathy, Transmissible Spongiform,Prion Induced Disorder,Prion Protein Disease,Spongiform Encephalopathy, Transmissible,Transmissible Dementia,Transmissible Spongiform Encephalopathy

Related Publications

Lars Redecke, and Stephan Binder, and Mohammed I Y Elmallah, and Rebecca Broadbent, and Claudia Tilkorn, and Benjamin Schulz, and Patrick May, and Arne Goos, and Andreas Eich, and Michael Rübhausen, and Christian Betzel
November 2016, Micromachines,
Lars Redecke, and Stephan Binder, and Mohammed I Y Elmallah, and Rebecca Broadbent, and Claudia Tilkorn, and Benjamin Schulz, and Patrick May, and Arne Goos, and Andreas Eich, and Michael Rübhausen, and Christian Betzel
January 2005, Medecine sciences : M/S,
Lars Redecke, and Stephan Binder, and Mohammed I Y Elmallah, and Rebecca Broadbent, and Claudia Tilkorn, and Benjamin Schulz, and Patrick May, and Arne Goos, and Andreas Eich, and Michael Rübhausen, and Christian Betzel
December 2023, Prion,
Lars Redecke, and Stephan Binder, and Mohammed I Y Elmallah, and Rebecca Broadbent, and Claudia Tilkorn, and Benjamin Schulz, and Patrick May, and Arne Goos, and Andreas Eich, and Michael Rübhausen, and Christian Betzel
February 2004, Proceedings of the National Academy of Sciences of the United States of America,
Lars Redecke, and Stephan Binder, and Mohammed I Y Elmallah, and Rebecca Broadbent, and Claudia Tilkorn, and Benjamin Schulz, and Patrick May, and Arne Goos, and Andreas Eich, and Michael Rübhausen, and Christian Betzel
January 1989, Acta physiologica Polonica,
Lars Redecke, and Stephan Binder, and Mohammed I Y Elmallah, and Rebecca Broadbent, and Claudia Tilkorn, and Benjamin Schulz, and Patrick May, and Arne Goos, and Andreas Eich, and Michael Rübhausen, and Christian Betzel
January 1990, Biofizika,
Lars Redecke, and Stephan Binder, and Mohammed I Y Elmallah, and Rebecca Broadbent, and Claudia Tilkorn, and Benjamin Schulz, and Patrick May, and Arne Goos, and Andreas Eich, and Michael Rübhausen, and Christian Betzel
October 2018, The Journal of biological chemistry,
Lars Redecke, and Stephan Binder, and Mohammed I Y Elmallah, and Rebecca Broadbent, and Claudia Tilkorn, and Benjamin Schulz, and Patrick May, and Arne Goos, and Andreas Eich, and Michael Rübhausen, and Christian Betzel
December 2005, The Journal of biological chemistry,
Lars Redecke, and Stephan Binder, and Mohammed I Y Elmallah, and Rebecca Broadbent, and Claudia Tilkorn, and Benjamin Schulz, and Patrick May, and Arne Goos, and Andreas Eich, and Michael Rübhausen, and Christian Betzel
January 2014, Prion,
Lars Redecke, and Stephan Binder, and Mohammed I Y Elmallah, and Rebecca Broadbent, and Claudia Tilkorn, and Benjamin Schulz, and Patrick May, and Arne Goos, and Andreas Eich, and Michael Rübhausen, and Christian Betzel
August 2006, Journal of virology,
Copied contents to your clipboard!